# A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

> **NCT00704444** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 11332 (actual)

## Conditions studied

- Hypercholesterolemia
- Familial Hypercholesterolemia
- Homozygous Sitosterolemia

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Ezetimibe + other lipid-lowering medication(s)

## Key facts

- **NCT ID:** NCT00704444
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 11332 (ACTUAL)
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704444, "A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00704444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*